2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

被引：0
|
作者：
N Ruperto
DJ Lovell
R Cuttica
P Woo
G Espada
C Wouters
ED Silverman
Z Balogh
M Henrickson
J Davidson
I Foeldvari
L Imundo
G Simonini
J Oppermann
YK Shen
S Visvanathan
A Fasanmade
A Mendelsohn
A Martini
EH Giannini
机构：
[1] IRCCS G Gaslini,
[2] Pediatria II – PRINTO,undefined
[3] Cincinnati Children's Hosp Med Center,undefined
[4] Hosp de Pediatria Dr Pedron de Elizalde,undefined
[5] Great Ormond St Hosp,undefined
[6] Hosp de Ninos Ricardo Gutierrez,undefined
[7] U Hosp Gathuisberg,undefined
[8] Hosp for Sick Children,undefined
[9] Royal Liverpool Childrens NHS Trust,undefined
[10] Eilbek Clinic,undefined
[11] Columbia/NY Presbyterian Hosp,undefined
[12] U Florence,undefined
[13] Kinderklinik,undefined
[14] Centocor R & D,undefined
[15] Inc,undefined
[16] National Inst Rheuma & Physiotherapy,undefined
[17] Children's Hospital,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Methotrexate; Infliximab; Juvenile Rheumatoid Arthritis; Core Variable; Active Arthritis;
D O I：
10.1186/1546-0096-6-S1-S3
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Safety and Efficacy of Long-term Sarilumab Treatment in Patients with Active Rheumatoid Arthritis: EXTEND and MONARCH Open Label Extension Studies
    Burmester, Gerd
    Strand, Vibeke
    Kivitz, Alan
    Hu, Chih-Chi
    Wang, Sheldon
    van Hoogstraten, Hubert
    Tao, Ray
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3521 - 3525
  • [32] AURANOFIN IN THE LONG-TERM TREATMENT OF CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS (JRA)
    GIANNINI, EH
    BREWER, EJ
    HE, X
    [J]. CLINICAL RESEARCH, 1985, 33 (04): : A919 - A919
  • [33] Safety and efficacy of tofacitinib for up to 9.5years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Wollenhaupt, Juergen
    Lee, Eun-Bong
    Curtis, Jeffrey R.
    Silverfield, Joel
    Terry, Ketti
    Soma, Koshika
    Mojcik, Chris
    DeMasi, Ryan
    Strengholt, Sander
    Kwok, Kenneth
    Lazariciu, Irina
    Wang, Lisy
    Cohen, Stanley
    [J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [34] Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years
    Wollenhaupt, Juergen
    Silverfield, Joel
    Lee, Eun Bong
    Terry, Ketti
    Kwok, Kenneth
    Strengholt, Sander
    DeMasi, Ryan
    Wang, Lisy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [35] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES OVER 8 YEARS
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Terry, K.
    Kwok, K.
    Abramsky, S.
    Wang, M.
    Nduaka, C.
    DeMasi, R.
    Wang, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 277 - 278
  • [36] Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension up to 6 Years.
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Wood, S. P.
    Terry, K.
    Nakamura, H.
    Kwok, K.
    Anisfeld, A.
    Nduaka, C.
    Riese, R.
    Wang, L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S375 - S375
  • [37] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES OVER 9 YEARS
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Terry, K.
    Kwok, K.
    Strengholt, S.
    DeMasi, R.
    Wang, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 978 - 978
  • [38] Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 8 Years
    Wollenhaupt, Juergen
    Silverfield, Joel
    Lee, Eun Bong
    Terry, Ketti
    Kwok, Kenneth
    Abramsky, Staci
    Wang, Min
    Nduaka, Chudy
    DeMasi, Ryan
    Wang, Lisy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [39] Long-term efficacy and toxicity of cyclosporin A plus fluocortolone plus methotrexate in the treatment of rheumatoid arthritis
    Pascalis, L
    Aresu, G
    Pia, G
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : 679 - 688
  • [40] Long-term safety and efficacy of adalimumab therapy in patients with juvenile rheumatoid arthritis (JRA) - Results from over 2 years of treatment
    Ruperto, N.
    Lovell, D. J.
    Goodman, S.
    Reiff, A.
    Nemcova, D.
    Prieur, A. M.
    Joos, R.
    McIlraith, M.
    Martini, Alberto
    Giannini, E.
    [J]. RHEUMATOLOGY, 2008, 47 : II2 - II3
12345